Authors:
Jansson, M
Backstrom, E
Scarlatti, G
Bjorndal, A
Matsuda, S
Rossi, P
Albert, J
Wigzell, H
Citation: M. Jansson et al., Length variation of glycoprotein 120 V2 region in relation to biological phenotypes and coreceptor usage of primary HIV type 1 isolates, AIDS RES H, 17(15), 2001, pp. 1405-1414
Authors:
Losman, B
Bolmstedt, A
Schonning, K
Bjorndal, A
Westin, C
Fenyo, EM
Olofsson, S
Citation: B. Losman et al., Protection of neutralization epitopes in the V3 loop of oligomeric human immunodeficiency virus type I glycoprotein 120 by N-linked oligosaccharides in the V1 region, AIDS RES H, 17(11), 2001, pp. 1067-1076
Citation: Kb. Hagen et al., A population study of factors associated with general practitioner consultation for non-inflammatory musculoskeletal pain, ANN RHEUM D, 59(10), 2000, pp. 788-793
Authors:
Jansson, M
Backstrom, E
Bjorndal, A
Holmberg, V
Rossi, P
Fenyo, EM
Popovic, M
Albert, J
Wigzell, H
Citation: M. Jansson et al., Coreceptor usage and RANTES sensitivity of non-syncytium-inducing HIV-1 isolates obtained from patients with AIDS, J HUMAN VIR, 2(6), 1999, pp. 325-338
Authors:
Bjorndal, A
Sonnerborg, A
Tscherning, C
Albert, J
Fenyo, EM
Citation: A. Bjorndal et al., Phenotypic characteristics of human immunodeficiency virus type 1 subtype C isolates of Ethiopian AIDS patients, AIDS RES H, 15(7), 1999, pp. 647-653
Authors:
Midthjell, K
Kruger, O
Holmen, J
Tverdal, A
Claudi, T
Bjorndal, A
Magnus, P
Citation: K. Midthjell et al., Rapid changes in the prevalence of obesity and known diabetes in an adult Norwegian population - The Nord-Trondelag Health Surveys: 1984-1986 and 1995-1997, DIABET CARE, 22(11), 1999, pp. 1813-1820
Authors:
Morner, A
Bjorndal, A
Albert, J
Kewalramani, VN
Littman, DR
Inoue, R
Thorstensson, R
Fenyo, EM
Bjorling, E
Citation: A. Morner et al., Primary human immunodeficiency virus type 2 (HIV-2) isolates, like HIV-1 isolates, frequently use CCR5 but show promiscuity in coreceptor usage, J VIROLOGY, 73(3), 1999, pp. 2343-2349